GlassScriptPhysician profile
Jack R Andrews
NPI 1396190336
$13,357.69
in general payments reported to CMS, 2019-2025
15 companies · $6,767 in 2025
The $6,767 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2021: $1,214 · 2022: $145 · 2023: $172 · 2024: $4,836 · 2025: $6,767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,542 · Food and Beverage: $2,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,542.00 |
| Food and Beverage | $2,232.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $5,793.07 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $3,622.31 | 2024-2025 | |
| Provepharm INC. | $1,310.00 | 2024 | Bludigo |
| Janssen Scientific Affairs, LLC | $1,154.74 | 2021-2024 | Erleada |
| Blue Earth Diagnostics | $569.05 | 2023-2025 | Posluma |
| Boston Scientific Corporation | $145.17 | 2022 | |
| Shockwave Medical, INC | $143.26 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $135.36 | 2021 | |
| Coloplast Corp | $128.09 | 2019 | |
| Progenics Pharmaceuticals, INC. | $124.99 | 2024 | |
| Astellas Pharma US INC | $96.44 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $68.15 | 2021 | |
| Sumitomo Pharma America, INC. | $38.72 | 2025 | Orgovyx |
| Cook Medical LLC | $28.34 | 2024 | Ncircle |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Andrews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.